News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anthera Pharmaceuticals, Inc. Sets IPO Terms, Will Price in the $13-$15 Per Share Range



2/3/2010 8:42:26 AM

Bookmark and Share

PEH -- Anthera Pharmaceuticals Inc., a San Mateo, Calif.-based developer of anti-inflammatory drugs, has set its proposed IPO terms to around 4.61 million common shares being offered at between $13 and $15 per share. The company plans to trade on the Nasdaq under ticker symbol ANTH, with Deutsche Bank Securities serving as lead underwriter.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES